
NVST Stock Forecast & Price Target
NVST Analyst Ratings
Bulls say
Envista Holdings Corp has recently demonstrated a positive turnaround in its sales performance, with Challenger (Value) Implant sales returning to growth after a prior decline, and Premium Implant revenue experiencing a global increase. Additionally, the company has raised its full-year 2025 core sales growth guidance from +1-3% to +3-4% year-over-year, underscoring its optimistic financial outlook. The notable growth in both the Wires & Brackets segment and overall stability in the Implant division further indicates the company's potential for continued revenue expansion within the dental products market.
Bears say
Envista Holdings Corp's financial outlook is negatively impacted by a $0.02 EBIT miss despite achieving top-line outperformance, reflecting potential operational inefficiencies. The company's maintained FY25 EBITDA margin guidance at approximately 14%, alongside a modestly improved core sales growth expectation of 150 basis points, suggests limited profit expansion potential. Additional risks highlighted include heightened competition, macroeconomic challenges, deficiencies in commercial execution, regulatory pressures, and reliance on distribution partners, all of which pose significant uncertainty to the company's future performance.
This aggregate rating is based on analysts' research of Envista Holdings Corp and is not a guaranteed prediction by Public.com or investment advice.
NVST Analyst Forecast & Price Prediction
Start investing in NVST
Order type
Buy in
Order amount
Est. shares
0 shares